Incorrect username and/or password, please try again or click to reset.

National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Emerade 500 micrograms and Emerade 300 micrograms auto-injectors, due to the potential for device failure, NatPSA/2023/004/MHRA

2023-05-09 11:30:14 (10 month(s) ago)

Summary

Pharmaswiss ńĆeska republika s.r.o. is initiating an urgent recall of all batches of Emerade 500 micrograms and Emerade 300 micrograms auto-injectors.

Read full MHRA article

Respond to this alert